5-HT3 antagonist
ABVD
ATC code L01
Abemaciclib
Aclarubicin
Adagrasib
Adenosine deaminase inhibitor
Aflibercept
Alabama
Alitretinoin
Alkyl sulfonate
Alkylating antineoplastic agent
Alkylation
Allergic reactions
Alpelisib
Altretamine
Alvocidib
American Society of Health-System Pharmacists
Aminolevulinic acid
Aminopterin
Amrubicin
Amsacrine
Anagrelide
Anatomical Therapeutic Chemical Classification System
Anthracycline
Anthraquinone
Antifolate
Antimetabolite
Antineoplastic
Aprepitant
Arsenic trioxide
Asparaginase
Asparagine
Atrasentan
Axicabtagene ciloleucel
Azacitidine
Aziridine
Bayer
Belinostat
Belotecan
Belzutifan
Bendamustine
Bexarotene
Bioavailability
Biological half-life
Bisantrene
Bleomycin
Bortezomib
Boxed warning
Brexucabtagene autoleucel
Busulfan
CAS Registry Number
Cabazitaxel
Camptotheca
Camptothecin
Capecitabine
Carboplatin
Carboquone
Carfilzomib
Carmofur
Carmustine
Celecoxib
Cell-cycle nonspecific antineoplastic agents
ChEBI
ChEMBL
ChemSpider
Chemical formula
Chemotherapy
Chemotherapy-induced nausea and vomiting
Chemotherapy medication
Chemotherapy regimen
Chlorambucil
Chlormethine
Ciltacabtagene autoleucel
Cisplatin
Cladribine
Clinical trial
Clofarabine
CompTox Chemicals Dashboard
Copanlisib
Cositecan
Crisnatol
Crosslinking of DNA
Cyclin-dependent kinase
Cyclophosphamide
Cytarabine
DNA polymerase inhibitor
DNA replication
Dacarbazine (data page)
Dactinomycin
Daunorubicin
Daunorubicin/cytarabine
Decitabine
Demecolcine
Denileukin diftitox
Deoxyribonucleotide
Dexamethasone
Dicycloplatin
Dihydrofolate reductase inhibitor
Dimethylamine
Docetaxel
Doi (identifier)
Doxifluridine
Doxorubicin
DrugBank
Drug metabolism
Drug nomenclature
Drugs.com
Duvelisib
ECHA InfoCard
Efaproxiral
Eflornithine
Elesclomol
Elsamitrucin
Enasidenib
Endothelin receptor antagonist
Entinostat
Enzyme inhibitor
Epacadostat
Epirubicin
Epothilone
Eribulin
Estramustine phosphate
Etirinotecan pegol
Etoglucid
Etoposide
Exatecan
Excretion
FDA
Farnesyltransferase inhibitor
Floxuridine
Fludarabine
Fluorouracil
Fotemustine
Fuzuloparib
Gemcitabine
Generic drug
Gimatecan
Glasdegib
Halogenation
Hdl (identifier)
Histone deacetylase inhibitor
History of cancer chemotherapy
Hodgkin's lymphoma
Hospira
Hydrazine
Hydroxycarbamide
Hypomethylating agent
IMP dehydrogenase
ISBN (identifier)
IUPAC nomenclature of chemistry
Idarubicin
Idecabtagene vicleucel
Idelalisib
Ifosfamide
Imetelstat
Inavolisib
Intercalation (biochemistry)
International Chemical Identifier
Intravenous
Intravenous therapy
Irinotecan
Isocitrate dehydrogenase
Ivosidenib
Ixabepilone
Ixazomib
JSmol
KEGG
Kidney
Larotaxel
Leukopenia
Lifileucel
Lipoxygenase inhibitor
Lisocabtagene maraleucel
List of withdrawn drugs
Liver problems
Lomustine
Lonidamine
Losoxantrone
Low platelets
Lucanthone
Lurbinectedin
Lurtotecan
M phase
Mannosulfan
Masoprocol
MedlinePlus
Melanoma
Melphalan
Melphalan flufenamide
Menogaril
Mercaptopurine
Metastasis
Methotrexate
Methyl aminolevulinate
Microtubule
Mitobronitol
Mitoguazone
Mitomycins
Mitotane
Mitotic inhibitor
Mitoxantrone
Mitozolomide
Molar mass
NK1 receptor antagonist
Nadofaragene firadenovec
Navitoclax
Nedaplatin
Nelarabine
Nimustine
Niraparib
Niraparib/abiraterone acetate
Nitrogen mustard
Nitrosourea
Nitrous acid
Obecabtagene autoleucel
Oblimersen
Olaparib
Olutasidenib
Omacetaxine mepesuccinate
Ondansetron
Oprozomib
Ortataxel
Oxaliplatin
PARP inhibitor
PMC (identifier)
PMID (identifier)
Paclitaxel
Padeliporfin
Palbociclib
Panobinostat
Pegaspargase
Pemetrexed
Pentostatin
Pharmacokinetics
Phases of clinical research
Phosphodiesterase inhibitor
Phosphoinositide 3-kinase inhibitor
Photodynamic therapy
Photosensitizer
Pipobroman
Pirarubicin
Pixantrone
Platinum-based antineoplastic
Plicamycin
Plitidepsin
Podophyllum peltatum
Porfimer sodium
Porphyrin
Pralatrexate
Prednimustine
Pregnancy
Procarbazine
Proteasome inhibitor
Protein kinase inhibitor
PubChem
Purine analog
Purine analogue
Pyrimidine analogue
Rabacfosadine
Raltitrexed
Ranimustine
Receptor antagonist
Regulation of therapeutic goods
Retinoid
Retinoid X receptor
Ribociclib
Ribonucleotide reductase inhibitor
Romidepsin
Route of administration
Rubitecan
Rucaparib
S2CID (identifier)
S phase
Sarcoma
Satraplatin
Seliciclib
Selinexor
Semustine
Sex steroid
Silatecan
Simplified molecular-input line-entry system
Sitimagene ceradenovec
Sotorasib
Southern Research
Spindle poison
Streptomyces
Streptozotocin
Tabelecleucel
Tagraxofusp
Talaporfin
Talimogene laherparepvec
Taxane
Tazemetostat
Tebentafusp
Tegafur
Tegafur/gimeracil/oteracil
Temoporfin
Temozolomide
Teniposide
Tesetaxel
Testolactone
Teva Pharmaceutical Industries
Thiopurine
Thiotepa
Thymidylate synthase inhibitor
Tiazofurin
Tiazofurine
Tigilanol tiglate
Tioguanine
Tipifarnib
Tisagenlecleucel
Topoisomerase inhibitor
Topotecan
Trabectedin
Treosulfan
Tretinoin
Triazene
Triaziquone
Triethylenemelamine
Trofosfamide
Type II topoisomerase
Type I topoisomerase
Umbralisib
Unique Ingredient Identifier
Uramustine
Valrubicin
Veliparib
Venetoclax
Verdinexor
Verteporfin
Vinblastine
Vinca alkaloid
Vincristine
Vindesine
Vinflunine
Vinorelbine
Vorasidenib
Vorinostat
Vosaroxin
WHO Model List of Essential Medicines
World Health Organization
Zorubicin